Gender is an age-specific effect modifier for papillary cancers of the thyroid gland

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1092-1100

  Kilfoy, Briseis A ^a,b   Devesa, Susan S ^a   Ward, Mary H ^a   Zhang, Yawei ^b   Rosenberg, Philip S ^a   Holford, Theodore R ^b   Anderson, William F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX RATIO; THYROID PAPILLARY CARCINOMA; TREND STUDY; UNITED STATES;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, STATISTICAL; SEX FACTORS; THYROID NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 66649101572     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0976     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96. Epub 2008 Feb 20.
2. Zheng T, Holford TR, Chen Y, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer 1996;67:504-509
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167
4. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 2005;62:156-162 (Pubitemid 40203909)
5. Albores-Saavedra J, Henson DE, Glazer E, Schwartz AM. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype-papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol 2007;18:1-7. (Pubitemid 47345617)
6. Anderson WF, Chen BE, Brinton LA, Devesa SS. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 2007;18:1187-1198 Epub 2007 Sep 6. (Pubitemid 47498167)
7. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 1987;6:449-467
8. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-period and age-cohort models. Stat Med 1987;6:469-481
9. Surveillance, Epidemiology, and End Results (SEER) Program. (November 2007 submission.). Public-Use Database (1973-2005), National Cancer Institute DCCPS, Suveillance Research Program, Cancer Statistics Branch, Released April 2008, based on the November 2007 submission.
10. Johnson CH, Adamo M, editors. SEER Program Coding and Staging Manual 2007. Bethesda (MD): National Cancer Institute; 2007. NIH Publication number 07-5581.
11. Surveillance Research Program. National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.4.4.
12. A note on the D method by Gary W. Oehlert. Am Stat 1992;46:27-29
13. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995;141:300-304
14. Holford TR. "The Estimation of Age, Period and Cohort Effects for Vital Rates." Biometrics 1983;39:311-324
15. Holford TR. Understanding the effects of age, period, and cohort on incidence andmortality rates [review].Annu Rev Public Health 1991;12:425-457
16. Tarone RE, Chu KC. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996;143:85-91. (Pubitemid 26011659)
17. Anderson WF, Rosenberg PS, Menashe I, et al. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 2008;17;100:1804-1814
18. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture [review]. Eur J Cancer 2001;37 Suppl 8:S4-66.
19. Vaidya B, Anthony S, Bilous M, et al. Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding? J Clin Endocrinol Metab 2007;92:203-207
20. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238 (Pubitemid 38082818)
21. Haddow J, McClain M, Palomaki G, Kloza E, Williams J. Screening for thyroid disorders during pregnancy: Results of a survey in Maine. Am J Obstet Gynecol 194:471-474 (Pubitemid 43183703)
22. Kilfoy BA, Zheng T, Han X, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes and Control. In press 2009.
23. Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10:143-155
24. La Vecchia C, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999;10:157-166
25. Memon A, Darif M, Al-Saleh K, Suresh A. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 2002;97:82-89
26. Zivaljevic V, Vlajinac H, Jankovic R, et al. Case-control study of female thyroid cancer-menstrual, reproductive and hormonal factors. Eur J Cancer Prev 2003;12:63-66 (Pubitemid 36233024)
27. Goodman MT, Kolonel LN, Wilkens LR. The association of body size, reproductive factors and thyroid cancer. Br J Cancer 1992;66:1180-1184 (Pubitemid 23006165)